1: Read U.S. customer reviews of Bubs Australia trial to get an idea of the quality of their formula and what to expect regarding FDA approval in October 2025. https://www.reddit.com/r/FormulaFeeders/comments/1fp5z3i/bubs_formula_trial/ 2. Bubs has grown its U.S. business by 26% pcp, despite Amazon temporarily suppressing some of its products due to pack format documentation compliance issues. This issue has now been resolved, and they anticipate Amazon sales to improve in Q3. 3. Bubs reaffirms FY25 outlook guidance of $102m revenue, gross margin > 40% and EBITDA breakeven 4. Bubs is backtesting, and many buyers entered at 11 cents. If a big whale bought at this level, they will likely support the price from dropping further. If the share price moves up from here, the next target is 14.5 cents
#DYOR
BUB Price at posting:
11.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)